Bunzl plc, the specialist international distribution and services Group, today announces the appointment of Dr. Pamela Kirby as a non-executive director and as a member of the Remuneration, Audit, Nomination and Board Sustainability Committees.

Pamela Kirby will join the Board and the aforesaid Committees with effect from 1 August 2022. She is presently a non-executive director of Reckitt Benckiser Group PLC and a member of the Supervisory Board of AkzoNobel N.V.

Pamela Kirby has significant knowledge and experience in global businesses, having worked in several international roles for over 30 years. She has held senior executive positions at AstraZeneca PLC and F. Hoffman-La Roche Ltd. and was formerly Chief Executive Officer of Quintiles Transnational Corporation. She was also previously a non-executive director of DCC plc, Hikma Pharmaceuticals PLC and Senior Independent Director of Victrex plc.

Commenting on the appointment, Peter Ventress, Chairman of Bunzl, said:

“I am delighted to welcome Pamela Kirby to Bunzl as a non-executive director. Through her executive and non-executive roles, she brings a wealth of international distribution, strategic and UK listed company experience to the Board and I am confident that she will enhance and strengthen the capabilities and diversity of the Board further.”

Enquiries:

Bunzl plc confirms that there are no other disclosures that need to be made under Listing Rule 9.6.13 in relation to Dr. Kirby’s appointment.

Board change - Dr. Pamela Kirby